NC Lawyers reviewing Byetta, Januvia, Victoza drugs due to their side effects for potential legal action. These drugs are injectable prescription medicines that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus. This drug works by stimulating insulin production. Some studies indicate these drugs have been linked to serious side effects, including pancreatitis, thyroid cancer and pancreatic cancer.
O'Malley Tunstall has handled numerous bad drug cases in the past. Currently we are reviewing the lawsuits and medicine involving all three of these diabetes medications.
Scientific studies have shown that certain types of diabetes drugs that affect the GLP-1 metabolic pathway – such as Byetta, Januvia, Janumet, and Victoza – can increase the risk of pancreatitis and pancreatic cancer. Beginning in 2007, the FDA began issuing multiple healthcare provider alerts noting the increased risk of acute pancreatitis in patients taking Byetta (exenatide), including both hemorrhagic and necrotizing pancreatitis. Lawsuits began to be filed against the maker of Byetta, Amylin Phamaceuticals, in 2008.
Many people who have suffered from these side effects have filed lawsuits against the makers of these drugs, Merck, Amylin, Eli Lilly and Bristol-Myers Squibb, and Novo Nordisk A/S.
The U.S. Food and Drug Administration approved Byetta, Januvia, Janumet and Victoza in 2005, 2006, 2007 and 2010, respectively. These drugs are classified as incretin mimetics. Since approving them, the FDA has issued warnings linking the drugs to serious complications such as pancreatic diseases.
Lawsuits allege that the drugmakers marketed these medications despite knowing that they were dangerous and failed to warn the public about the risk of pancreatic cancer and pancreatitis.
O'Malley Tunstall, PLLC are NC Lawyers reviewing Byetta, Januvia, Victoza especially cases involving patients who have developed pancreatic cancer after taking Byetta, Januvia and Victoza. Give us a call to discuss.